Tau is a candidate gene for chromosome 17 frontotemporal dementia

Annals of Neurology
P PoorkajG D Schellenberg

Abstract

Frontotemporal dementia with parkinsonism, chromosome 17 type (FTDP-17), a recently defined disease entity, is clinically characterized by personality changes sometimes associated with psychosis, hyperorality, and diminished speech output, disturbed executive function and nonfluent aphasia, bradykinesia, and rigidity. Neuropathological changes include frontotemporal atrophy often associated with atrophy of the basal ganglia, substantia nigra, and amygdala. Neurofibrillary tangles (NFTs) are seen in some but not all families. Inheritance is autosomal dominant and the gene has been regionally localized to 17q21-22 in a 2- to 4-centimorgan (cM) region flanked by markers D17S800 and D17S791. The gene for tau, the primary component of NFTs, is located in the same region of chromosome 17. Tau was evaluated as a candidate gene. Physical mapping studies place tau within 2 megabases or less of D17S791, but it is probably outside the D17S800-D17S791 FTDP-17 interval. DNA sequence analysis of tau coding regions in affected subjects from two FTDP-17 families revealed nine DNA sequence variants, eight of which were also identified in controls and are thus polymorphisms. A ninth variant (Val279Met) was found in one FTDP-17 family but not in ...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D CouchieJ Nunez
Nov 3, 1992·Biochemistry·A AndreadisK S Kosik
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M GoedertR A Crowther
May 25, 1992·Nucleic Acids Research·C T AmemiyaP J de Jong
Nov 1, 1991·The Journal of Cell Biology·K A Butner, M W Kirschner
Mar 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·D NearyP Goulding
Sep 1, 1987·Archives of Gerontology and Geriatrics·A Brun
Jun 1, 1996·Annals of Neurology·A A SimaK C Wilhelmsen
Oct 25, 1996·Science·G D SchulerT J Hudson
Dec 1, 1996·The Journal of Cell Biology·I Irminger-FingerS J Edelstein
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniB Ghetti
Aug 1, 1997·American Journal of Human Genetics·T A Cooper, W Mattox
Nov 5, 1997·American Journal of Human Genetics·J R MurrellB Ghetti

❮ Previous
Next ❯

Citations

May 21, 2003·Archives of Neurology·Maria-Jesús SobridoDaniel H Geschwind
Apr 13, 2011·Archives of Neurology·Alice S Chen-PlotkinVivianna M Van Deerlin
Mar 11, 1999·Annals of Neurology·J L Price, J C Morris
Oct 8, 1999·Annals of Neurology·J C van SwietenP Heutink
Jul 14, 2000·Annals of Neurology·S D GinsbergJ Q Trojanowski
Feb 28, 2001·Annals of Neurology·T D Bird, G D Schellenberg
Sep 24, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·H R MorrisN W Wood
Mar 14, 2002·Annals of Neurology·Manabu FunayamaFumiya Obata
Mar 14, 2002·Annals of Neurology·Sonia M RossoJohn C van Swieten
Mar 29, 2002·Annals of Neurology·Shintaro HayashiHitoshi Takahashi
Sep 27, 2002·Annals of Neurology·Parvoneh PoorkajGerard D Schellenberg
Nov 26, 2002·Annals of Neurology·Patrice VerpillatUNKNOWN French Study Group on Alzheimer's Disease and Frontotemporal Dementia
Oct 17, 2001·Annals of Neurology·M NeumannH A Kretzschmar
Apr 5, 2002·The Journal of Comparative Neurology·Feng BianLary C Walker
Oct 23, 2002·Journal of Neuroscience Research·Maho Morishima-Kawashima, Yasuo Ihara
Nov 22, 2002·Journal of Neuroscience Research·Henry G TomasiewiczJohn G Wood
Aug 2, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·Z K WszolekR F Pfeiffer
Jul 3, 2007·Cellular and Molecular Life Sciences : CMLS·K Iqbal, I Grundke-Iqbal
Jun 28, 2011·Cellular and Molecular Life Sciences : CMLS·Jürgen GötzXin Liu
Sep 6, 2008·Der Pathologe·M Neumann, H A Kretzschmar
Jul 2, 2008·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Gareth T BanksElizabeth M C Fisher
Jan 13, 2005·Acta Neuropathologica·Khalid Iqbal, Inge Grundke-Iqbal
Dec 23, 2006·Acta Neuropathologica·Salvatore SpinaCatherine Keohane
Jun 19, 2007·Acta Neuropathologica·Stuart M Pickering-Brown
Sep 6, 2007·Acta Neuropathologica·Stephan FrankMarkus Tolnay
Feb 3, 2009·Acta Neuropathologica·Khalid IqbalInge Grundke-Iqbal
Nov 8, 2011·Acta Neuropathologica·Juan F ReyesLester I Binder
Aug 15, 2012·Acta Neuropathologica·Anne SiebenMarc Cruts
Oct 12, 2013·Acta Neuropathologica·Rachel M BaileyJada Lewis
Jun 9, 2005·Journal of Neurology·Giorgio GiacconeFabrizio Tagliavini
Apr 26, 2012·Journal of Neurology·Chiara CeramiDaniela Galimberti
Apr 5, 2007·Cell and Tissue Research·Xinping ChenAike Guo
Apr 25, 2012·Journal of Neural Transmission·Daniela Galimberti, Elio Scarpini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.